Srinagesh HK, Jackson C, Shiraz P, Jeyakumar N, et al. A Phase 1 Clinical Trial of NKTR-255 with CD19-22 CAR-T Cell Therapy for Refractory B-cell Acute Lymphoblastic Leukemia. Blood 2024 Jul 5:blood.2024024952. doi: 10.1182/blood.2024024952.
PMID: 38968138